These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An 81 year old man with a blistering rash. Noel S; Dua J; Kaushal G BMJ; 2013 Jan; 346():f522. PubMed ID: 23369776 [No Abstract] [Full Text] [Related]
3. [Bullous pemphigoid, primary biliary cirrhosis and vitiligo: a multiple autoimmune syndrome?]. Marcet B; Sibaud V; Géniaux M; Taieb A Ann Med Interne (Paris); 2002 Sep; 153(5):349-50. PubMed ID: 12442082 [TBL] [Abstract][Full Text] [Related]
9. Complete remission of MDS RAEB following immunosuppressive treatment in a patient with Sweet's syndrome. Ten Oever J; Kuijper PH; Kuijpers AL; Dercksen MW; Vreugdenhil G Neth J Med; 2009 Sep; 67(8):347-50. PubMed ID: 19767665 [TBL] [Abstract][Full Text] [Related]
10. Evidence-based management of bullous pemphigoid. Daniel BS; Borradori L; Hall RP; Murrell DF Dermatol Clin; 2011 Oct; 29(4):613-20. PubMed ID: 21925006 [TBL] [Abstract][Full Text] [Related]
11. Dyshidrosiform palmoplantar pemphigoid in a young man: response to dapsone. Lupi F; Masini C; Ruffelli M; Puddu P; Cianchini G Acta Derm Venereol; 2010; 90(1):80-1. PubMed ID: 20107732 [No Abstract] [Full Text] [Related]
12. A progressive pruritic rash with blisters. Overcash MD; Ewald M JAAPA; 2016 May; 29(5):60-1. PubMed ID: 27124233 [TBL] [Abstract][Full Text] [Related]
13. Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid. Kasperkiewicz M; Hoppe U; Zillikens D; Schmidt E Clin Exp Dermatol; 2010 Aug; 35(6):614-7. PubMed ID: 19874345 [TBL] [Abstract][Full Text] [Related]
14. First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid. Cho YT; Chu CY; Wang LF Br J Dermatol; 2015 Jul; 173(1):302-4. PubMed ID: 25529394 [No Abstract] [Full Text] [Related]
15. A retrospective review of the therapeutic response with remission in patients with newly diagnosed bullous pemphigoid. Chuah SY; Tan SH; Chua SH; Tang MB; Lim YL; Neoh CY; Tan AW Australas J Dermatol; 2014 May; 55(2):149-51. PubMed ID: 24720427 [TBL] [Abstract][Full Text] [Related]
17. Changes in the autoimmune blistering response: a clinical and immunopathological shift from pemphigus foliaceus to bullous pemphigoid. Maeda JY; Moura AK; Maruta CW; Santi CG; Prisayanh PS; Aoki V Clin Exp Dermatol; 2006 Sep; 31(5):653-5. PubMed ID: 16901304 [TBL] [Abstract][Full Text] [Related]
18. Bullous pemphigoid in a renal transplant recipient: a case report and review of the literature. Chen TJ; Lai PC; Yang LC; Kuo TT; Hong HS Am J Clin Dermatol; 2009; 10(3):197-200. PubMed ID: 19354335 [TBL] [Abstract][Full Text] [Related]
19. [Bullous pemphigoid. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie]. Bernard P; Bedane C; Prost C; Ingen-Housz-Oro S; Joly P; Ann Dermatol Venereol; 2011 Mar; 138(3):247-51. PubMed ID: 21397154 [No Abstract] [Full Text] [Related]
20. Bullous pemphigoid masquerading as recurrent vesicular hand eczema. Veien NK Acta Derm Venereol; 2010; 90(1):4-5. PubMed ID: 20107717 [No Abstract] [Full Text] [Related] [Next] [New Search]